Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner herbal products pace 30% net sales gain to $122.3 mil. in fiscal first quarter.

This article was originally published in The Tan Sheet

Executive Summary

LEINER HERBAL PRODUCT REVENUES PACE 30% NET SALES JUMP to $122.3 mil. in the fiscal first quarter ended June 30, the dietary supplement marketer reported in a teleconference with securities analysts Aug. 10. Revenues for the company's herbal line rose 157% to $22.2 mil. from $8.6 mil. in the prior-year period, Leiner Health Products CEO Robert Kaminski said. In contrast, he noted total herbal category sales were up 87% for the 13 weeks ended June 28, according to data from Chicago-based Information Resources, Inc. for food, drug and mass merchandise outlets. Leiner private-label herbal sales jumped 122%, "more than 40% faster than the total market," Kaminski added.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088761

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel